Daniel Lu
Impact in
- Hepatology top 10%
- Liver physiology and pathology
-
- Lung Cancer Treatments and Mutations
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Epigenetics and DNA Methylation 1
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- William W. Lockwood (9 shared papers)Romel Somwar (5 shared papers)Alexander Drilon (2 shared papers)Marc Ladanyi (3 shared papers)Maria E. Arcila (2 shared papers)Ken Suzawa (2 shared papers)Charles M. Rudin (2 shared papers)Michael Offin (2 shared papers)
- Journals
- Cancers (2 papers)European Journal Of Haematology (1 paper)Clinical Cancer Research (1 paper)The Journal of Immunology (1 paper)Blood (1 paper)
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
Daniel Lu
12 papers receiving 277 citations
Peers
Comparison fields: 5 of 40
- Hepatology 51
- Pulmonary and Respiratory Medicine 115
- Cancer Research 45
- Pathology and Forensic Medicine 49
- Genetics 28
Countries citing papers authored by Daniel Lu
This map shows the geographic impact of Daniel Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lu more than expected).
Fields of papers citing papers by Daniel Lu
This network shows the impact of papers produced by Daniel Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lu. The network helps show where Daniel Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 84 | |
| 2 | 2019 | 49 | |
| 3 | 2019 | 43 | |
| 4 | 2018 | 37 | |
| 5 | 2021 | 23 | |
| 6 | 2018 | 14 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 9 | |
| 9 | 2025 | 4 | |
| 10 | 2015 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2024 | 1 |
About Daniel Lu
Daniel Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Genetics, having authored 12 papers that have together received 278 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer Mechanisms and Therapy (1 paper), Epigenetics and DNA Methylation (1 paper), Ubiquitin and proteasome pathways (1 paper), Lung Cancer Research Studies (1 paper), Protein Degradation and Inhibitors (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Hepatology (51 citations), Pulmonary and Respiratory Medicine (115 citations), Cancer Research (45 citations), Pathology and Forensic Medicine (49 citations) and Genetics (28 citations). Daniel Lu has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include William W. Lockwood, Romel Somwar, Alexander Drilon, Marc Ladanyi, Maria E. Arcila, Ken Suzawa, Charles M. Rudin, Michael Offin, Inna Khodos and Danelle F. James. Their work appears in journals such as Cancers, European Journal Of Haematology, Clinical Cancer Research, The Journal of Immunology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.